NCT00639249View on ClinicalTrials.gov

Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2009

Conditions
Ischemic Stroke
Interventions
DRUG

placebo

Oral administration

DRUG

SA4503 Low

Oral administration

DRUG

SA4503 High

Oral administration

Trial Locations (1)

Unknown

Southern General Hospital, Glasgow

Sponsors
All Listed Sponsors
lead

M's Science Corporation

INDUSTRY

NCT00639249 - Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke | Biotech Hunter | Biotech Hunter